RANK Ligand Inhibitor
5 drugs across 2 manufacturers|0 Generic,5 Brand
The RANK Ligand Inhibitor class contains 5 NDCs from 2 manufacturers (0 generic, 5 brand), at an average NADAC of $1853.55 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
5
0G / 5B
Manufacturers
2
Avg $1853.5454/unit
Avg 7d Change
0.00%
Across 0 drugs with changes
7d Activity
of 5 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
2 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
XGEVA 120 MG/1.7 ML VIAL denosumab | $2001.5168 per ML | — |
XGEVA 120 MG/1.7 ML VIAL denosumab | $2001.5168 per ML | — |
PROLIA 60 MG/ML SYRINGE denosumab | $1863.7230 per ML | 0.00% |
PROLIA 60 MG/ML SYRINGE denosumab | $1863.7230 per ML | 0.00% |
JUBBONTI 60 MG/ML SYRINGE denosumab | $1537.2474 per ML | 0.00% |
Frequently Asked Questions
How many drugs are in the RANK Ligand Inhibitor class?
The RANK Ligand Inhibitor class contains 5 NDCs from 2 manufacturers — 0 generic and 5 brand products.
What is the average price of RANK Ligand Inhibitor drugs?
The average NADAC for the RANK Ligand Inhibitor class is $1853.5454 per unit across 5 NDCs.
Which manufacturers make RANK Ligand Inhibitor drugs?
2 manufacturers make drugs in the RANK Ligand Inhibitor class. Ranked by number of NDCs, the largest are Amgen Inc. (4), Sandoz Inc. (1).